在患有原发性低血清炎的患者接受葡萄糖皮质类药物治疗后完全缓解
Aysa Hacioglu1, Gazanfer Ekinci2, Zuleyha Karaca1
1Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey.
Endocrinology, diabetes & metabolism case reports
|October 11, 2024
概括
初级低血位炎是一种罕见的垂体疾病,可以有效地用葡萄糖皮质类药物治疗. 一次类固醇疗程在轻度至中度病例中导致完全缓解,突显了它们的潜在疗效.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 放射学 放射学是一门学科.
背景情况:
- 原发性低性炎是一种罕见的炎症状况,影响着垂体腺.
- 治疗方案包括观察,免疫抑制剂和手术,用葡萄糖皮质激素作为第一线治疗.
- 不响应和复发是管理hypophysitis的重大挑战.
研究的目的:
- 报告一例原发性低血清炎病例,该病例对单次葡萄糖皮质类药物治疗有很好的反应.
- 讨论类固醇治疗在轻度至中度病例中潜在的疗效.
主要方法:
- 一名30岁的男性患者患有急性发病症状,并在MRI上显示了脑下垂体质量,他接受了甲基prednisolone治疗.
- 用临床表现,荷尔蒙评估和连续的脑部MRI来评估治疗反应.
- 在6个月内监测了荷尔蒙功能和垂体质量回归.
主要成果:
- 患者出现了头痛和脑下垂体质量,导致光学隙压缩.
- 激素评估表明前垂体功能障碍,不包括生长激素轴.
- 部MRI显示,在二个月的甲基前尼索隆治疗后,垂体质量完全回归.
- 六个月后,下垂体功能完全恢复.
结论:
- 葡萄糖皮质类药物治疗可以在实现原发性低血压炎缓解方面非常有效,特别是在轻度至中度病例中.
- 一次类固醇疗程可能足以治疗,即使在较低剂量.
- 个性化治疗策略是非常重要的,考虑到hypophysitis的多样化的临床过程.
更多相关视频
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
18.8K
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
1.3K
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:15Hypoglycemia and Glucagon
164
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
164
01:37Hypothalamic-Pituitary Axis
59.5K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
59.5K